NCT04183166TG4050Mayo ClinicHNSCCSouth Central - Oxford
…Background In the phase I trial TG4050.02 ( NCT04183166) evaluating TG4050 in resected, locally advanced HNSCC patients…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 781–840 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Alcon Healthcare1Alder Hey Children’s Charity1Alexander von Humboldt Foundation1Alex’s Lemonade Stand Foundation1Algemene Pharmaceutische Bond1All of Us Research Program1Allergan Aesthetics1Alliance for Innovation on Maternal Health1Amazon1Amazon Mechanical Turk1American Academy of Paediatrics1American Academy of Pediatrics1American Academy of Sleep Medicine1American Association for Accreditation of Laboratory Animal Care1American Association for Cancer Research1American Association for Hand Surgery1American Association for Surgery of Trauma Disaster Committee1American Association of Clinical Endocrinology71American Association of Laboratory Animal Care1American Association of Laboratory Animal Committee1American Australian Association Graduate Education Scholarship1American Cancer Society1American Cancer Society Research Scholar Grant1American Climate Corps1American Clinical Neurophysiology Society1American College of Obstetricians and Gynaecologists1American College of Obstetricians and Gynecologists1American College of Surgeons Trauma Quality Improvement Program1American Epilepsy Society1American Heart Association GWTG-Stroke Program1American Institute for Cancer Research1American Italian Cancer Foundation1American Medical Association House of Delegates1American Medical Society for Sports Medicine1American Neurogastroenterology and Motility Society1American Psychiatric Association1American Psychological Association1American Society for Transplantation and Cellular Therapy1American Society of Regional Anesthesia and Pain Medicine Board of Directors1American Stroke Association1American Surgical Association Research Award1American-Italian Cancer Foundation1Amicus Therapeutics1Analgesic Stewardship Committee1Anticoagulation Forum1Aotearoa New Zealand Health and Disability Commissioner1Area Vasta Emilia Centro Ethics Committee1Arizona Department of Health Services1Arms industry1Army Command1Arrythmia Alliance1Arthritis Society1Asian Pacific Association of Gastroenterology1Asociación Empresarial del Tabaco1Asociación Española de Angioedema Familiar1Aspetar1Association for Assessment and Accreditation of Laboratory Animal Care International1Association for Assessment of Laboratory Animal Care1Association for Palliative Medicine of Great Britain and Northern Ireland1Association of British Neurologists1
Articles mentioning funders
5,089 articles · page 330 of 425NCT04162015nivolumabDiffuse pleural mesotheliomapemetrexedcisplatincarboplatinplatinumP/D
…exed prior to P/D (2 cycles) for patients with resectable DPM ( NCT04162015).Methods To comprehensively assess tumor and immune microenviro…
Bristol-Myers Squibbneoadjuvant immunotherapynivolumabEGFR-mutant NSCLCchemotherapyCTONG1104
…and families involved in this study. This work was supported by Bristol-Myers Squibb, Guangdong Provincial Key Lab of Translational Medicine in Lung…
Foundation for the National Institutes of Health, Inc.CAN-2409docetaxelNSCLCsacituzumab govitecanvalacyclovir
…oject was made possible through funding support provided to the Foundation for the National Institutes of Health, Inc. (FNIH) by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma…
AstraZenecadurvalumabcapivasertibDurvaolaparibOlaCaprelapse/refractory solid cancers
…ing macrophages and stromal cells are underway.Acknowledgements AstraZeneca’s support is gratefully acknowledgedTrial Registration NCT03772…
Astellas Pharma Inc.ASP1012la/m solid tumorsadvanced solid tumorsOxford PharmaGenesis Inc.
…uding 3×10 9 pfu/dose.Acknowledgements This study was funded by Astellas Pharma Inc. Medical writing support, conducted in accordance with Good Publ…
IRB00115160cemiplimabEmory Universitymetastatic cutaneous squamous cell carcinoma (CSCC)
…proval The study was approved by the Emory IRB (approval number IRB00115160) and participants gave informed consent to take part in this st…
FDAMitazalimabmFOLFIRINOX
… Journal for ImmunoTherapy of Cancer 2024;12(Suppl 2):A677–A678.FDA. Optimizing the dose of human prescription drugs and biological…
FDAEVOLVE104EIU-104101urothelial carcinomasquamous cell carcinomasCohort BCohort AEVOLVE TCEstransitional cell carcinomas of the urinary tractlocally advanced or metastatic solid tumors
…g.Ethics Approval Study EIU-104101 is currently under review by FDA and will only begin enrollment upon clearance from relevant hea…
American Surgical Association Research AwardAppendiceal cancerMD Anderson Cancer CenterBarnes-Jewish HospitalpaclitaxelUniversity of Texas MD Anderson Cancer Centercolorectal cancerWashington University Institutional Review Board
…cy.Acknowledgements This work was supported by funding from the American Surgical Association Research Award (Dr. Beth A. Helmink), NIH grant R37AI049653 (Dr. Gwendalyn J. …
PHASE ONE FoundationECOG Performance StatusDana-Farber Cancer InstituteIL-12myeloid leukemiaIL-15IL-18PROCpembrolizumabDana-Farber/Harvard Cancer Center+6 more
…uable. The authors are deeply grateful for funding support from PHASE ONE Foundation and from Pan-Mass Challenge Team Ovarian Cancer.References Disi…
Mount Sinai PPHS IRBHNSCCimmunotherapyMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)
…drivers of immunotherapy resistance among HNSCC.Ethics Approval Mount Sinai PPHS IRB approved STUDY-21-01683…